Artificial Intelligence In Cancer Research
The August 7th show features
(NASDAQ Trading Symbol: AIPT)
formerly Skyline Medical.
Precision Therapeutics is at the Forefront in Medical Advancement and Innovation.
The Company Arose as a Joint Venture Between Skyline Medical and Helomics. Precision Therapeutics Is Now Bringing Precision Medicine to the Diagnosis and Treatment of Cancer.
Harnessing the power of artificial intelligence, Precision Therapeutics is working with the pharmaceutical, diagnostic and biotech industries to develop highly customizable assessment methods for cancer patients, which is leading to much more effective treatments for the patients of today and tomorrow.
Listen to the Interview:
See the Precision Therapeutics Website: PrecisionTherapeutics.com
See the Investors Information Page
Precision Therapeutics Is at the Forefront in Medical Advancement and Innovation. The Company Arose as a Joint Venture Between Skyline Medical and Helomics. Skyline Medical’s Automated ‘streamway’ System Transformed How Laboratories Safely Dispose of Medical Fluid Waste. By Joining Forces with Helomics, Precision Therapeutics Is Now Bringing Precision Medicine to the Diagnosis of Cancer. Harnessing the Power of Artificial Intelligence, Precision Therapeutics Is Working with the Pharmaceutical, Diagnostic and Biotech Industries to Develop Highly Customizable Assessment Methods for Cancer Patients, Leading to Much More Effective Treatments.
Precision Therapeutics (NASDAQ: AIPT) operates in two business areas: first, applying artificial intelligence to personalized medicine and drug discovery to provide personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and second, production of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, through its Skyline Medical division.
Skyline Medical Inc. has a fully automated, patented, and FDA cleared surgical fluid disposal device-the STREAMWAY System-that virtually eliminates operating room workers’ exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment.
Crystal Research Issues AIPT Executive Informational Overview
See corporate site: SkylineMedical.com
Skyline Medical’s Automated ‘Streamway’ System Transformed How Laboratories Safely Dispose of Medical Fluid Waste.
See corporate website: Helomics.com
Helomics® is a precision diagnostic company and integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace.
Helomics has established operations that bridge two emerging areas of the healthcare industry: precision medicine and big data. Helomics’ competitive advantage lies in its proprietary D-CHIP™ database, which contains de-identified data compiled from more than a decade of clinical testing of tumor responses to drugs coupled to an Artificial Intelligence (AI) -powered bioinformatics engine which generates actionable scientific insights from this rich data. These insights are used by BioPharma companies in the research and development of targeted cancer treatments for any given patient profile.
Mr. Vardzel has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh
AI in Cancer Stock News
Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System — See News
Precision Therapeutics Inc., a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that on July 11, 2018 the European Patent Office granted European Patent No. 2948200 covering the Company’s STREAMWAY® System for automated, direct-to-drain medical fluid disposal, which is sold through the Company’s Skyline Medical division.
Precision Therapeutics Signs Definitive Merger Agreement with Helomics Holding Corporation — See News
Precision Therapeutics Inc., a company focused on applying artificial intelligence to personalized medicine and drug discovery, is pleased to announce that it has signed a definitive merger agreement with Helomics Holding Corporation (“Helomics”). Upon completion of the merger, Precision will increase its equity stake in Helomics from 25% to 100%. This merger will provide Precision Therapeutics with full access to Helomics’ suite of Artificial Intelligence (AI), precision diagnostic and integrated CRO capabilities, which improve patient care and advance the development of innovative clinical products and technologies for the treatment of cancers.
More on Skyline Medical Inc. medical waste disposal systems products
Skyline Medical Inc.’s STREAMWAY System fully automates the collection, measurement and disposal of surgical fluids, which results in:
- Reducing overhead costs to hospitals and surgical centers
- Improving their Occupational Safety and Health Administration (OSHA) and other regulatory compliance
- Enhancing the efficiency of the operating room and thereby making surgeries more profitable
Skyline Medical Inc.’s STREAMWAY System is eco-friendly as it addresses the numerous bloody, potentially disease infected canisters that go into U.S. landfills every year. These tainted canisters—which are generally made of plastic—can take centuries to biodegrade, but with installations of the STREAMWAY System, the number of these canisters can be significantly reduced.
The new standard in waste fluid management.
The STREAMWAY System installs in or on the wall with direct-to-drain fluid removal medical product for safe, continuous collection and disposal. The illuminated touch screen provides safe control over surgical suction levels and displays automated measurement of volumes, while the single patient procedure filter and tissue trap both prevents cross contamination and allows for tissue retrieval. To clean, simply detach the filter, connect the cleaning solution bottle and activate the rapid clean cycle using the touch screen.
Investment News Show
Money Info Show Airs
10 AM to 11 AM EDT
Use this Link To Watch The Show:
The Princeton Research Money Info show features where to invest now, stock market, business, economy and financial investment news.
The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, Florida — The Talk of the Treasure Coast
Money Info is hosted by investing experts Mike King and Charles Moskowitz together with radio broadcasting professional Greg Wyatt.
Undervalued Medical Stocks
Medical Products Company Stock News
Artificial Intelligence In Cancer Research